Apr.30
11:14 AM ET
Monday, 30 Apr 2012
Posted By:ReutersCNBC Stock Blog Europe
AstraZeneca may be lacking both drugs and a CEO, but for brave investors this might be the time to buy the stock. Read More
VIDEO | COMPANIES : Forest Laboratories Inc
Mark Matthews, Head of Research Asia, Bank Julius Baer warns there's a lot of policy risk in the month ahead, and that J...
Charles Leyland, Managing Director, Leyland Private Asset Management argues that investors should take advantage of the ...
Chris Viehbacher, CEO, Sanofi says the firm has been built so that it could grow without having to rely on the research ...
Discussing whether the Facebook IPO is over-hyped or not, with the Fast Money traders, and Sam Schwerin, Millennium Tech...
You say the name of a stock, and Mad Money's Jim Cramer tells you whether to buy or sell.
More VideosNews |
COMPANY : Forest Laboratories Inc
Data is a real-time snapshot *Data is delayed at least 15 minutesGlobal Business and Financial News, Stock Quotes, and Market Data and Analysis
© 2012 CNBC LLC. All Rights Reserved.
